Zurich Cantonal Bank
ORTX

Zurich Cantonal Bank’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Zurich Cantonal Bank’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,135
Closed -$47K – 2641
2020
Q3 		$47K Hold
1,135
– – ﹤0.01% 2271
2020
Q2 		$68K Hold
1,135
– – ﹤0.01% 2116
2020
Q1 		$85K Hold
1,135
– – ﹤0.01% 1698
2019
Q4 		$156K Buy
+1,135
New +$138K ﹤0.01% 1468

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Zurich Cantonal Bank's ORTX Position: Q4 2020 in Review

Zurich Cantonal Bank sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2020, closing a stake of 1,135 shares — an estimated $47K sold.

Zurich Cantonal Bank first reported a position in ORTX in Q4 2019 and held it in 4 quarters. The position peaked at $156K in Q4 2019. 77 funds tracked by Wall St. Rank hold ORTX as of Q4 2020.

  • Zurich Cantonal Bank reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,135 Orchard Therapeutics plc American Depositary Shares shares in Q4 2020, an estimated $47K.
  • Zurich Cantonal Bank first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 4 quarters.
  • Zurich Cantonal Bank's Orchard Therapeutics plc American Depositary Shares position peaked at $156K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2020.

Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.